| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Research |
1 Department of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas and 2 Division of Molecular and Genomic Medicine, National Health Research Institutes, 128 Yen-Chiu-Yuan Road, sec. 2, Taipei, 115, Taiwan
Requests for reprints: Mien-Chie Hung, Department of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-792-3668; Fax: 713-794-0209. E-mail: mhung{at}mdanderson.org.
Epidermal growth factor receptor (EGFR) has been detected in the nucleus of cancer cells and primary tumors for decades. While localized in the nucleus, EGFR functions as a transcriptional regulator resulting in the activation of the cyclin D1 gene. Despite nuclear accumulation of EGFR is linked to increased DNA synthesis and proliferative potential, the pathological significance of nuclear EGFR, however, remains uninvestigated. Furthermore, expression of EGFR has not provided a consistent predictive value for survival of breast cancer patients. Here, we analyzed 130 breast carcinomas via immunohistochemical analyses for the levels of nuclear and non-nuclear EGFR. We found 37.7% of the cohort immunostained positively for nuclear EGFR and 6.9% with high levels of expression. Importantly, Kaplan-Meier survival analysis and log-rank test revealed a significant inverse correlation between high nuclear EGFR and overall survival (P = 0.009). Expression of nuclear EGFR correlated positively with increased levels of cyclin D1 and Ki-67, both are indicators for cell proliferation. In contrast, expression of non-nuclear EGFR did not significantly correlate with those of cyclin D1 and Ki-67 or the overall survival rate. In addition, we analyzed 37 oral squamous carcinomas for EGFR expression and found 24.3% of the cases to contain moderate/high levels of nuclear EGFR. Taken together, our findings indicate pathological significance of nuclear EGFR and may have important clinical implication.
Key Words: ErbB • breast cancer • protein tyrosine kinases • cancer pathology
This article has been cited by other articles:
|
|
 |
|
  Involvement of the HER2 pathway in repair of DNA damage produced by chemotherapeutic agents Mol. Cancer Ther., November 1, 2009; 8(11): 3015 - 3023.
|
|
|
|
 |
|
 S.-C. Wang and M.-C. Hung Nuclear Translocation of the Epidermal Growth Factor Receptor Family Membrane Tyrosine Kinase Receptors Clin. Cancer Res., November 1, 2009; 15(21): 6484 - 6489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-W. Lo, X. Cao, H. Zhu, and F. Ali-Osman Constitutively Activated STAT3 Frequently Coexpresses with Epidermal Growth Factor Receptor in High-Grade Gliomas and Targeting STAT3 Sensitizes Them to Iressa and Alkylators Clin. Cancer Res., October 1, 2008; 14(19): 6042 - 6054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Naresh, A. D. Thor, S. M. Edgerton, K. C. Torkko, R. Kumar, and F. E. Jones The HER4/4ICD Estrogen Receptor Coactivator and BH3-Only Protein Is an Effector of Tamoxifen-Induced Apoptosis Cancer Res., August 1, 2008; 68(15): 6387 - 6395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-Y. Hung, J. T. Tseng, Y.-C. Lee, W. Xia, Y.-N. Wang, M.-L. Wu, Y.-H. Chuang, C.-H. Lai, and W.-C. Chang Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression Nucleic Acids Res., August 1, 2008; 36(13): 4337 - 4351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Scaltriti and J. Baselga The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 91 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Seethala, W. E. Gooding, P. N. Handler, B. Collins, Q. Zhang, J. M. Siegfried, and J. R. Grandis Immunohistochemical Analysis of Phosphotyrosine Signal Transducer and Activator of Transcription 3 and Epidermal Growth Factor Receptor Autocrine Signaling Pathways in Head and Neck Cancers and Metastatic Lymph Nodes Clin. Cancer Res., March 1, 2008; 14(5): 1303 - 1309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-W. Lo, S.-C. Hsu, W. Xia, X. Cao, J.-Y. Shih, Y. Wei, J. L. Abbruzzese, G. N. Hortobagyi, and M.-C. Hung Epidermal Growth Factor Receptor Cooperates with Signal Transducer and Activator of Transcription 3 to Induce Epithelial-Mesenchymal Transition in Cancer Cells via Up-regulation of TWIST Gene Expression Cancer Res., October 1, 2007; 67(19): 9066 - 9076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kim, W. J. Jahng, D. Di Vizio, J. S. Lee, R. Jhaveri, M. A. Rubin, A. Shisheva, and M. R. Freeman The Phosphoinositide Kinase PIKfyve Mediates Epidermal Growth Factor Receptor Trafficking to the Nucleus Cancer Res., October 1, 2007; 67(19): 9229 - 9237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, M. Zheng, G. Liu, W. Xia, P. J. McKeown-Longo, M.-C. Hung, and J. Zhao Kruppel-Like Factor 8 Induces Epithelial to Mesenchymal Transition and Epithelial Cell Invasion Cancer Res., August 1, 2007; 67(15): 7184 - 7193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-C. Hsu and M.-C. Hung Characterization of a Novel Tripartite Nuclear Localization Sequence in the EGFR Family J. Biol. Chem., April 6, 2007; 282(14): 10432 - 10440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-J. Liao and G. Carpenter Role of the Sec61 Translocon in EGF Receptor Trafficking to the Nucleus and Gene Expression Mol. Biol. Cell, March 1, 2007; 18(3): 1064 - 1072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sawada, A. R. Radjabi, N. Shinomiya, E. Kistner, H. Kenny, A. R. Becker, M. A. Turkyilmaz, R. Salgia, S. D. Yamada, G. F. Vande Woude, et al. c-Met Overexpression Is a Prognostic Factor in Ovarian Cancer and an Effective Target for Inhibition of Peritoneal Dissemination and Invasion Cancer Res., February 15, 2007; 67(4): 1670 - 1679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Scaltriti and J. Baselga The epidermal growth factor receptor pathway: a model for targeted therapy. Clin. Cancer Res., September 15, 2006; 12(18): 5268 - 5272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Chung, K. Ely, L. McGavran, M. Varella-Garcia, J. Parker, N. Parker, C. Jarrett, J. Carter, B. A. Murphy, J. Netterville, et al. Increased Epidermal Growth Factor Receptor Gene Copy Number Is Associated With Poor Prognosis in Head and Neck Squamous Cell Carcinomas J. Clin. Oncol., September 1, 2006; 24(25): 4170 - 4176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. H. Koumakpayi, J.-S. Diallo, C. Le Page, L. Lessard, M. Gleave, L. R. Begin, A.-M. Mes-Masson, and F. Saad Expression and Nuclear Localization of ErbB3 in Prostate Cancer. Clin. Cancer Res., May 1, 2006; 12(9): 2730 - 2737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Lee, S. Dedhar, R. Kalluri, and E. W. Thompson The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J. Cell Biol., March 27, 2006; 172(7): 973 - 981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Friedmann, M. Caplin, B. Savic, T. Shah, C. J. Lord, A. Ashworth, J. A. Hartley, and D. Hochhauser Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment. Mol. Cancer Ther., February 1, 2006; 5(2): 209 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Giri, M. Ali-Seyed, L.-Y. Li, D.-F. Lee, P. Ling, G. Bartholomeusz, S.-C. Wang, and M.-C. Hung Endosomal Transport of ErbB-2: Mechanism for Nuclear Entry of the Cell Surface Receptor Mol. Cell. Biol., December 15, 2005; 25(24): 11005 - 11018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kim, R. M. Adam, and M. R. Freeman Trafficking of Nuclear Heparin-Binding Epidermal Growth Factor-like Growth Factor into an Epidermal Growth Factor Receptor-Dependent Autocrine Loop in Response to Oxidative Stress Cancer Res., September 15, 2005; 65(18): 8242 - 8249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Prognostic Value of Nuclear EGFR Cancer Res., March 1, 2005; 65(5): 2045b - 2045b. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
